Database Query Results : Vitamin B12, ,
VitB12, Vitamin B12: Click to Expand ⟱
| Features: |
Helps make red blood cells, metabolize food and prevent nerve damage.
|
Scientific Papers found: Click to Expand⟱
*other↑, *other↓, *cognitive↑, *eff↑, *eff↑,
*cognitive↑, *cognitive↑, *Inflam↓, *homoC↓, *TNF-α↓, *other↝, *memory↑,
other↓, other↝, homoC↓, eff↝, other↝,
*BDNF↑, *homoC↓,
homoC↓, eff↑, eff↑, eff↑, eff↝, homoC↝, other?,
*homoC↓, *cognitive∅,
*cognitive↑, *homoC↓, *other↝, *other↝,
Risk↓, eff↝, eff↝, homoC↓,
homoC↓, eff↝,
*homoC↓, *cognitive↑,
*cognitive↑, *Mood↑,
*cognitive↑,
*other↓, *other↑, *other↑,
*homoC↓, *cognitive↑,
*homoC↓, *cognitive↑,
*Risk∅, *cognitive↑, *cognitive∅,
*homoC↓, *neuroP↑, *cognitive↑,
*cognitive↑, *homoC↓, *SAM-e↓,
neuroP↑,
*homoC↓, *other↝, *other↝,
*cognitive↝,
*cognitive↑,
*homoC↓, *cognitive↑, *memory↑, *other↑,
*other↑, *other↑, *eff↝, *homoC↓, *cognitive↑,
*cognitive∅,
*cognitive↑, *other↝,
*memory↑, *neuroP↑, *cognitive↑, *QoL∅,
*cognitive↑,
*antiOx↑, *ROS↓, *GSH↑, *Inflam↓, *IL6↓, *TNF-α↓, *other↑, *other↑, *other↑, *Aβ↓, *memory↑, *p‑tau↓, *APP↓, *BACE↓, *ATP↑, *neuroP↑,
*Risk↓, *Risk∅,
*Risk↓, *Risk↓, *Risk↓, *cognitive↑,
*cognitive∅, *cognitive↑,
*antiOx↑, *cognitive↑, *homoC↓, *Risk↓, *Risk↓, *Risk↓, *other↝, *Dose↝, *Risk↓, *Risk↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 33
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, GSH↑, 1, ROS↓, 1, SAM-e↓, 1,
Mitochondria & Bioenergetics ATP production, membrane potential, mitochondrial signaling, and dynamics (fission, fusion, mitophagy). It includes mitochondrial contributions to apoptosis, metabolism, and redox signaling. Mitochondrial dysfunction is a core driver of cancer metabolism, neurodegeneration, and age-related decline." style="cursor:help;color:#555;font-weight:normal;">ⓘ
ATP↑, 1,
Core Metabolism/Glycolysis ⓘ
homoC↓, 13,
Transcription & Epigenetics ⓘ
other↓, 2, other↑, 9, other↝, 7,
Migration ⓘ
APP↓, 1,
Immune & Inflammatory Signaling Inflammation group includes innate and adaptive immune pathways, cytokines, chemokines, pattern-recognition receptors, complement, and inflammasomes. It regulates host defense, tumor immunity, neuroinflammation, and chronic inflammatory disease processes." style="cursor:help;color:#555;font-weight:normal;">ⓘ
IL6↓, 1, Inflam↓, 2, TNF-α↓, 2,
Synaptic & Neurotransmission memory, and neuronal survival, and is especially relevant to Alzheimer’s and other neurodegenerative diseases." style="cursor:help;color:#555;font-weight:normal;">ⓘ
BDNF↑, 1, p‑tau↓, 1,
Protein Aggregation tau biology, proteolytic processing, and aggregate toxicity. It captures molecular features specific to neurodegenerative pathology but remains extensible to other aggregation disorders." style="cursor:help;color:#555;font-weight:normal;">ⓘ
Aβ↓, 1, BACE↓, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1, eff↑, 2, eff↝, 1,
Clinical Biomarkers Inflammation state | Microenvironment | Research-stage |
| 28 | XIST | Epigenetic instability | Aggressiveness | Not yet clinical |
| 29 | FOXM1 | High-risk biology | Aggressiveness | No routine testing |
| 30 | TRIB3 | Stress adaptation | Aggressiveness | Mechanistic, not clinical |
Core Liver & Systemic Biomarkers in Oncology
| Marker | What It Reflects | Main Use in Cancer | Decision Impact |
| --------- | ----------------------------------- | ----------------------------------------- | ----------- |
| ALT | Hepatocellular injury | Baseline eligibility, toxicity monitoring | High |
| AST | Liver + systemic injury | Detect liver injury, muscle involvement | High |
| ALP | Cholestasis, bone turnover | Liver mets vs bone mets | High |
| bilirubin | Hepatic clearance | Chemotherapy dosing | Critical |
| albumin | Synthetic liver function, nutrition | Prognosis, frailty | High |
| LDH | Tumor burden, hypoxia | Aggressiveness, prognosis | High |
| INR | Liver synthetic failure | Treatment safety | High |
Key Inflammatory / Host-Response Biomarkers Used in Oncology
| Biomarker | What It Reflects | Main Use in Cancer | Clinical Decision Impact |
| ------------------ | -------------------------------- | ---------------------------- | -------------------- |
| C-reactive protein | Systemic inflammation | Prognosis, therapy tolerance | High |
| ESR | Chronic inflammation | Disease activity trend | Moderate |
| ferritin | Inflammation + iron status | Cachexia, cytokine load | High |
| IL-6 | Cytokine signaling | Aggressiveness, cachexia | High (specialty use) |
| LDH | Tumor burden + hypoxia | Risk stratification | Very high |
| albumin | Nutritional & inflammatory state | Frailty, survival | Very high |
</pre>
" style="cursor:help;color:#555;font-weight:normal;">ⓘ
IL6↓, 1,
Functional Outcomes cognitive performance, toxicity, and organism-level effects. It is intentionally mechanism-agnostic and anchors molecular data to real-world biological impact." style="cursor:help;color:#555;font-weight:normal;">ⓘ
cognitive↑, 21, cognitive↝, 1, cognitive∅, 4, memory↑, 4, Mood↑, 1, neuroP↑, 3, QoL∅, 1, Risk↓, 9, Risk∅, 2,
Total Targets: 30
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:165 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page